Ironwood Pharmaceuticals | IRWD - Créances Commerciales





Créances Commerciales Changement Date
Acadia Pharmaceuticals USD 148.38M 153K 2026-03
Agios Pharmaceuticals USD 16.13M 5.56M 2026-03
Akebia Therapeutics USD 47.03M 19.19M 2025-12
Almirall EUR 175.93M 17.87M 2025-12
Alnylam Pharmaceuticals USD 883.96M 106.39M 2026-03
Amarin USD 126.83M 477K 2025-12
Ardelyx USD 71.85M 4.76M 2025-12
Astellas Pharma JPY 761.76B 48.47B 2026-03
AstraZeneca USD 17.88B 1.17B 2026-03
Charles River Laboratories USD 700.25M 727.92M 2026-03
Coherus Biosciences USD 18.42M 232.08M 2025-12
Emergent BioSolutions USD 290.1M 134.2M 2023-06
Esperion Therapeutics USD 140.19M 21.21M 2025-12
Halozyme Therapeutics USD 457.99M 16.72M 2026-03
Incyte USD 1.05B 27.09M 2026-03
Ironwood Pharmaceuticals USD 81.89M 5.68M 2024-12
Karyopharm Therapeutics USD 26.18M 5.6M 2025-12
Lexicon Pharmaceuticals USD 2.38M 50K 2025-12
MacroGenics USD 13.37M 55.86M 2025-12
Moderna USD 71M 113M 2026-03
Myriad Genetics USD 115.3M 2.7M 2025-12
Pacira USD 125.64M 1.57M 2026-03
PTC Therapeutics USD 181.62M 21.45M 2025-12
Puma Biotechnology USD 28.1M 3.52M 2024-06
Sarepta Therapeutics USD 547.91M 149.68M 2026-03
Takeda JPY 876.35B 118.43B 2026-03
Ultragenyx Pharmaceutical USD 60M 98M 2026-03
Vanda Pharmaceuticals USD 47.1M 4.35M 2024-12